These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1030275)

  • 1. A slow-release preparation of isoniazid: pharmacological aspects.
    Ellard GA
    Bull Int Union Tuberc; 1976; 51(1):144-54. PubMed ID: 1030275
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic studies with an isoniazid slow-releasing matrix preparation.
    Eidus L; Hodgkin MM; Hsu AH; Schaefer O
    Am Rev Respir Dis; 1974 Jul; 110(1):34-42. PubMed ID: 4834616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Compounding of pure tablets of isoniazid with prolonged action].
    Seleznev EF; Korobkov ES; Griniuk IL
    Farmatsiia; 1978; 27(4):24-6. PubMed ID: 357190
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver function in patients with pulmonary tuberculosis receiving maximal toeerable doses of isoniazid].
    Voskresenskiĭ ON; Gavrilenko VS; Iqnatova AV; Semenova VN; Starostenko EV
    Probl Tuberk; 1977; (2):31-5. PubMed ID: 866308
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of some slow-release preparations of isoniazid of potential use in intermittent treatment of tuberculosis.
    Ellard GA; Gammon PT; Lakshminarayan S; Fox W; Aber VR; Mitchison DA; Citron KM; Tall R
    Lancet; 1972 Feb; 1(7746):340-3. PubMed ID: 4109735
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acetylation of p-aminosalicylic acid and isoniazid in the perfused liver as a competitive enzymatic process].
    Wagner J; Dolezal V
    Acta Univ Carol Med (Praha); 1965; ():Suppl 21:165+. PubMed ID: 5880954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isoniazid metabolism and the indicators of bioelectric activity of the brain in patients with tuberculosis during treatment with increased doses of isoniazid].
    Vilenskaia RN; Chelnokova NV
    Probl Tuberk; 1976; 3():46-9. PubMed ID: 967856
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of isoniazid in humans. Reflexions of a practical nature].
    Fantoli U
    Lotta Tuberc; 1966; 36(7):231-45. PubMed ID: 5235940
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of isoniazid in patients with pulmonary tuberculosis].
    Protsiuk RG; Petrenko VI
    Sov Med; 1985; (3):94-8. PubMed ID: 4023845
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hematic concentrations of free isoniazid after rectal administration].
    Cassetti B; Pirolli T
    Ann Ist Carlo Forlanini; 1966; 26(4):508-13. PubMed ID: 5991602
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.
    Brennan RW; Dehejia H; Kutt H; McDowell F
    Neurology; 1968 Mar; 18(3):283. PubMed ID: 5690351
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
    Dal Negro R; Turco P; Trevisan F; De Conti F
    Int J Clin Pharmacol Res; 1988; 8(4):275-7. PubMed ID: 3182118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience of acceptability of slow release matrix isoniazid.
    Polansky F; Viznerova S; Vodrazkova A; Stott H
    Bull Int Union Tuberc; 1976; 51(1):155-8. PubMed ID: 1030276
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of immediate adverse reactions to different doses of a slow-release preparation of isoniazid.
    Parthasarathy R; Devadatta S; Fox W; Krishnaswami KV; Radhakrishna S; Somasundaram PR; Tripathy SP
    Tubercle; 1976 Jun; 57(2):115-21. PubMed ID: 785735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
    Zhang LX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
    [No Abstract]   [Full Text] [Related]  

  • 17. [A comparative study of tubazid inactivation in patients with pulmonary tuberculosis with fractional and single daily doses].
    Vilenskaia RN; Grebennik LI; Adamovich VN
    Probl Tuberk; 1969; 47(3):43-9. PubMed ID: 5354635
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognosis of isoniazid-resistant patients of pulmonary tuberculosis].
    Yoshida F; Liu C
    Kekkaku; 1987 Jan; 62(1):17-24. PubMed ID: 3573507
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tracheobronchial administration of isoniazid after preliminary inhalation anesthesia].
    Savula MM; Piatnochka IT; Rybak LD
    Probl Tuberk; 1980 Jul; (7):30-3. PubMed ID: 7413631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged-action antitubercular preparation].
    Sokirko TA; Klimenko MT
    Vrach Delo; 1987 Aug; (8):56-8. PubMed ID: 3120416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.